As of Nov 22, 2024, the Hims & Hers Health stock's P/E ratio is 53.89. This results from the current EPS of $0.47 and stock price of $25.33.
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
HIMS's PE ratio is above its peer stock NBIX.
Stock name | PE ratio | Market cap |
---|---|---|
NBIX Neurocrine Biosciences Inc | 32.55 | $12.72B |
HIMS Hims & Hers Health Inc | 53.89 | $5.53B |
NVAX Novavax Inc | N/A | $1.36B |
NVCR NovoCure Ltd | N/A | $1.92B |
The price to earnings ratio for HIMS stock as of Nov 22, 2024, stands at 53.89.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Nov 22, 2024), Hims & Hers Health's stock price is $25.33. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.47. Therefore, Hims & Hers Health's price to earnings ratio for today is 53.89. PE RATIO(53.89) = STOCK PRICE($25.33) / TTM EPS($0.47)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.